Therapeutic potential and mechanistic insights of silibinin targeting cancer-associated fibroblasts in colorectal cancer
ObjectiveThis study aims to elucidate the role of SB in inhibiting CRC progression by targeting CAFs and elucidating the underlying mechanisms.MethodsIn this study, a spontaneous CRC model induced by AOM/DSS was used to evaluate the effects of SB on CAFs. Mice were treated with SB, and tumor burden...
Saved in:
| Main Authors: | Shenglan He, Jianmei Ji, Kaisi Zhu, Youlan Chen, Xiaowen Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1527871/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytotoxic Effects of Silibinin in Combination with 5-Fluorouracil on HT29 Colorectal Cancer Cells
by: Bahman Moradi Poodeh
Published: (2025-01-01) -
Synergistic inhibition of gastric cancer cell proliferation by concanavalin A and silibinin via attenuation of the JAK/STAT3 signaling pathway and molecular docking analysis
by: Gaoyan Hua, et al.
Published: (2025-05-01) -
Identification of cancer-associated fibroblast signature genes for prognostic prediction in colorectal cancer
by: Wei Jin, et al.
Published: (2025-02-01) -
Cancer-associated fibroblasts in carcinogenesis
by: Shufen Zhou, et al.
Published: (2025-01-01) -
Current perspectives and trends in colorectal cancer and cancer-associated fibroblasts: a review and bibliometric analysis
by: Chengyong Qian, et al.
Published: (2025-07-01)